• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类酪氨酸激酶2缺陷揭示了其在先天免疫和获得性免疫相关的多种细胞因子信号传导中的必要作用。

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

作者信息

Minegishi Yoshiyuki, Saito Masako, Morio Tomohiro, Watanabe Ken, Agematsu Kazunaga, Tsuchiya Shigeru, Takada Hidetoshi, Hara Toshiro, Kawamura Nobuaki, Ariga Tadashi, Kaneko Hideo, Kondo Naomi, Tsuge Ikuya, Yachie Akihiro, Sakiyama Yukio, Iwata Tsutomu, Bessho Fumio, Ohishi Tsutomu, Joh Kosuke, Imai Kohsuke, Kogawa Kazuhiro, Shinohara Miwa, Fujieda Mikiya, Wakiguchi Hiroshi, Pasic Srdjan, Abinun Mario, Ochs Hans D, Renner Eleonore D, Jansson Annette, Belohradsky Bernd H, Metin Ayse, Shimizu Norio, Mizutani Shuki, Miyawaki Toshio, Nonoyama Shigeaki, Karasuyama Hajime

机构信息

Department of Immune Regulation, Graduate School, Tokyo Medical and Dental University, Yushima, Tokyo, Japan.

出版信息

Immunity. 2006 Nov;25(5):745-55. doi: 10.1016/j.immuni.2006.09.009.

DOI:10.1016/j.immuni.2006.09.009
PMID:17088085
Abstract

Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family. Here we identified a homozygous Tyk2 mutation in a patient who had been clinically diagnosed with hyper-IgE syndrome. This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE. The patient's cells displayed defects in multiple cytokine signaling pathways including those for type I interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23. The cytokine signals were successfully restored by transducing the intact Tyk2 gene. Thus, the Tyk2 deficiency is likely to account for the patient's complex clinical manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation. This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.

摘要

酪氨酸激酶2(Tyk2)是一种非受体酪氨酸激酶,属于Janus激酶(Jak)家族。在此,我们在一名临床诊断为高IgE综合征的患者中鉴定出纯合Tyk2突变。该患者对包括病毒、真菌和分枝杆菌在内的多种微生物表现出异常易感性,并患有特应性皮炎,血清IgE升高。患者的细胞在多种细胞因子信号通路中存在缺陷,包括I型干扰素(IFN)、白细胞介素(IL)-6、IL-10、IL-12和IL-23的信号通路。通过转导完整的Tyk2基因,细胞因子信号得以成功恢复。因此,Tyk2缺陷可能是导致该患者复杂临床表现的原因,包括辅助性T细胞1(Th1)分化受损和Th2分化加速的表型。本研究鉴定出人类Tyk2缺陷,并证明Tyk2在人类先天和后天免疫所涉及的多种细胞因子信号中起关键作用,这与Tyk2在小鼠中的功能有很大不同。

相似文献

1
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.人类酪氨酸激酶2缺陷揭示了其在先天免疫和获得性免疫相关的多种细胞因子信号传导中的必要作用。
Immunity. 2006 Nov;25(5):745-55. doi: 10.1016/j.immuni.2006.09.009.
2
Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency.
Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):506-9. doi: 10.1097/ACI.0b013e3282f1baea.
3
Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.Jak-STAT介导的细胞因子信号缺陷导致高IgE综合征:来自原发性免疫缺陷的教训。
Int Immunol. 2009 Feb;21(2):105-12. doi: 10.1093/intimm/dxn134. Epub 2008 Dec 15.
4
Human tyk2 kinase deficiency: another primary immunodeficiency syndrome.人类酪氨酸激酶2(TYK2)激酶缺乏症:另一种原发性免疫缺陷综合征。
Immunity. 2006 Nov;25(5):695-7. doi: 10.1016/j.immuni.2006.10.007.
5
Hyper-IgE syndrome.高免疫球蛋白 E 综合征。
Curr Opin Immunol. 2009 Oct;21(5):487-92. doi: 10.1016/j.coi.2009.07.013. Epub 2009 Aug 28.
6
Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome.
Eur J Clin Invest. 2005 Nov;35(11):718-21. doi: 10.1111/j.1365-2362.2005.01564.x.
7
Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.酪氨酸激酶 2 并不限制人体抗病毒的 III 型干扰素反应。
Eur J Immunol. 2016 Nov;46(11):2639-2649. doi: 10.1002/eji.201646519. Epub 2016 Oct 5.
8
Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia.复合杂合 TYK2 突变导致 T 细胞淋巴细胞减少症的原发性免疫缺陷。
Sci Rep. 2018 May 3;8(1):6956. doi: 10.1038/s41598-018-25260-8.
9
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.酪氨酸激酶 2 变体影响 T 淋巴细胞极化和多发性硬化症易感性。
Brain. 2011 Mar;134(Pt 3):693-703. doi: 10.1093/brain/awr010.
10
Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.严重甲型流感病毒感染中的高细胞因子血症和磷酸化p38丝裂原活化蛋白激酶的过度激活。
Clin Infect Dis. 2007 Sep 15;45(6):723-31. doi: 10.1086/520981. Epub 2007 Aug 8.

引用本文的文献

1
Mepolizumab treatment in a child with inherited TYK2 deficiency.美泊利单抗治疗一名患有遗传性酪氨酸激酶2缺乏症的儿童。
J Hum Immun. 2025 Sep;1(3). doi: 10.70962/jhi.20250106. Epub 2025 Jul 29.
2
Hyperimmunoglobulin syndromes: A review of HIGM, HIES, and HIDS.高免疫球蛋白综合征:高IgM综合征、高IgE综合征和高IgD综合征综述。
J Transl Autoimmun. 2025 Jun 27;11:100297. doi: 10.1016/j.jtauto.2025.100297. eCollection 2025 Dec.
3
Pathological IgE Production in Inborn Errors of Immunity and Beyond.免疫先天性疾病及其他情况下的病理性IgE产生
Immunol Rev. 2025 Jul;332(1):e70053. doi: 10.1111/imr.70053.
4
A new heterozygous TYK2 gene mutation: Case report and review of the literature.一种新的杂合型酪氨酸激酶2(TYK2)基因突变:病例报告及文献综述
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251351138. doi: 10.1177/03946320251351138. Epub 2025 Jun 30.
5
Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review.成人高免疫球蛋白E综合征患者的肺部特征及疾病分期:一项单中心临床研究及文献综述
Orphanet J Rare Dis. 2025 Jun 3;20(1):270. doi: 10.1186/s13023-025-03749-6.
6
The Dual-Edged Sword: Risks and Benefits of JAK Inhibitors in Infections.双刃剑:JAK抑制剂在感染中的风险与益处
Pathogens. 2025 Mar 27;14(4):324. doi: 10.3390/pathogens14040324.
7
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.JAK-STAT信号通路、I/II型细胞因子与自身免疫性大疱性疾病的新潜在治疗策略:寻常型天疱疮和大疱性类天疱疮的最新进展
Front Immunol. 2025 Apr 8;16:1563286. doi: 10.3389/fimmu.2025.1563286. eCollection 2025.
8
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review.德卡伐替尼在银屑病之外不断扩展的治疗潜力:一篇叙述性综述。
J Clin Med. 2025 Mar 5;14(5):1745. doi: 10.3390/jcm14051745.
9
Exploring the Efficacy, Safety, and Clinical Implications of Deucravacitinib in East Asians with Psoriasis: A Narrative Review.探索德卡伐替尼在东亚银屑病患者中的疗效、安全性及临床意义:一项叙述性综述
J Clin Med. 2025 Mar 5;14(5):1746. doi: 10.3390/jcm14051746.
10
Hyper IgE Syndrome: Bridging the Gap Between Immunodeficiency, Atopy, and Allergic Diseases.高免疫球蛋白E综合征:弥合免疫缺陷、特应性和过敏性疾病之间的差距。
Curr Allergy Asthma Rep. 2025 Mar 14;25(1):17. doi: 10.1007/s11882-025-01196-8.